Clinical Trials Browser

Phase 2 × INDUSTRY × BI 2536 × Clear all

NCT00412880 2022-06-22

BI 2536 Second Line Monotherapy in SCLC

Phase 2 Completed

23 enrolled 10 charts

Carcinoma, Small Cell

NCT00376623 2022-06-21

Efficacy and Safety of BI 2536 in Advanced or Metastatic Non Small Cell Lung Cancer

Phase 2 Completed

96 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung

NCT00710710 2022-05-04

Open, Randomized Phase II Trial to Investigate the Efficacy and Safety of the PLK-1 Inhibitor BI 2536 in Patients With Advanced, Unresectable Pancreatic Cancer

Phase 2 Completed

89 enrolled 20 charts

Gastrointestinal

Pancreatic Neoplasms

NCT00701766 2014-05-16

BI 2536 Infusional Treatment in Patients Over 60 Years of Age With Refractory or Relapsed Acute Myeloid Leukaemia

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00706498 2014-05-16

Phase II Study of BI 2536 in Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms